PharmiWeb.com - Global Pharma News & Resources

Marketing - Press Releases

Date Title Company
23-Sep-2020 Salvia BioElectronics raises EUR 26M (USD 31M) to develop innovative neurostimulation therapy for chronic migraine Salvia BioElectronics
23-Sep-2020 Aqualung Therapeutics Corp. Awarded $300K from NIH to Develop A Novel Therapeutic For Pregn Aqualung Therapeutics
23-Sep-2020 Janssen Presents Findings from Global, Multi-Centre Trial Examining Amivantamab in Combination with Lazertinib in Patients with EGFR-Mutated Non-Small Cell Lung Cancer The Janssen Pharmaceutical Companies of Johnson & Johnson
23-Sep-2020 Lynparza reduced the risk of death by 31% in BRCA1/2 or ATM-mutated metastatic castration-resistant prostate cancer in PROfound Phase III trial AstraZeneca
23-Sep-2020 PureTech Plans U.S. Listing on Nasdaq Global Market PureTech Health
23-Sep-2020 Helsinn supports the PhD program 2020-2021 of the Institute of Oncology Research (IOR) of the Faculty of Biomedical Sciences at the Università della Svizzera italiana (USI) Helsinn
22-Sep-2020 Roxtec supplies seals for hazardous areas to pharmaceutical group Guerbet during Dublin site upgrade Roxtec UK & Ireland
21-Sep-2020 Late-breaking ESMO presentation shows Libtayo® (cemiplimab) monotherapy increases overall survival in first-line advanced non-small cell lung cancer with PD-L1 expression of ≥50% Sanofi
21-Sep-2020 ABBOTT RECEIVES CE MARK FOR NEXT-GENERATION MITRACLIP™ HEART VALVE REPAIR DEVICE TO TREAT MITRAL REGURGITATION Abbott
21-Sep-2020 Genmab and Seattle Genetics Present Data from Tisotumab Vedotin innovaTV 204 Pivotal Trial in Recurrent or Metastatic Cervical Cancer at ESMO Virtual Congress 2020 Genmab
18-Sep-2020 Envision Pharma Group scoops two Silvers at the PM Society Digital Awards 2020 Envision Pharma Group
18-Sep-2020 SciBite launches state-of-the-art AI platform for Life Sciences organisations SciBite
18-Sep-2020 Positive clinical results for TG4001 and TG6002 and financial visibility secured until 2022 Transgene
18-Sep-2020 OXFORD BIOMEDICA PLC INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2020 Oxford Biomedica plc
18-Sep-2020 NOVO VENTURES CO-LEADS US$83M SERIES C FINANCING IN LAVA THERAPEUTICS About Novo Holdings A/S
18-Sep-2020 PARTNERSHIP ACCELERATES DRUG DEVELOPMENT Quay Pharma
18-Sep-2020 Liverpool John Moores University gives students a Better insight into e-prescribing Liverpool John Moores University
18-Sep-2020 Chi-Med Announces Second NDA Acceptance in China for Surufatinib in Pancreatic Neuroendocrine Tumors Surufatinib
18-Sep-2020 Oxurion NV Business Update and First Half 2020 Financial Results to be announced on 17 September Oxurion
18-Sep-2020 Helsinn Group and Italfarmaco announce oral presentation of NEPA (netupitant and palonosetron) data at ESMO Virtual Congress 2020 Helsinn